HCi Viocare, formerly China Northern Medical Device, Inc., is a start-up enterprise. The Company is engaged in the research and development and marketing of medical technologies, and the operation of prosthetics and orthotics (P&O) and diabetic foot total rehabilitation clinics. It is also engaged in the technology development and licensing of bioengineering innovations for the health, sports and wellness sectors. It was formed to sell medical devices with an emphasis on portable medical devices designed for home treatments with the initial focus in the northern regions of China. It intends to seek strategic relationships with medical device manufacturers both in China and North America with the aim to be their sales and distribution agent in Northern China and to assist Chinese medical device manufacturers on the development of the North American market. Its subsidiaries include HCi Viocare Technologies Limited, HCi Viocare Clinics UK Limited and HCi Viocare Clinics (Hellas) S.A.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCBB:VICA
- CUSIP: N/A
- Web: www.hciviocare.com/
- Market Cap: $30.59 million
- Outstanding Shares: 195,064,000
- 52 Week Range: $0.08 - $2.00
Sales & Book Value:
- Trailing P/E Ratio:
- P/E Growth:
- Annual Revenue: $633,368.00
- Price / Sales: 48.29
- Book Value: ($0.01) per share
- Price / Book: -22.40
- EBIDTA: ($1,190,000.00)
- Net Margins: -853.37%
- Return on Assets: -934.78%
- Average Volume: 11,206 shs.
Frequently Asked Questions for HCi VioCare (OTCBB:VICA)
What is HCi VioCare's stock symbol?
HCi VioCare trades on the OTCBB under the ticker symbol "VICA."
Who are HCi VioCare's key executives?
HCi VioCare's management team includes the folowing people:
- Sotirios Leontaritis, Chief Executive Officer, Chief Financial Officer, Treasurer, Director
- Nicolaos Kardaras, Secretary, Director
- Christos Kapatos, Director
- Yannis Levantis, Director
How do I buy HCi VioCare stock?
Shares of HCi VioCare can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HCi VioCare's stock price today?
MarketBeat Community Rating for HCi VioCare (OTCBB VICA)MarketBeat's community ratings are surveys of what our community members think about HCi VioCare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of HCi VioCare stock can currently be purchased for approximately $0.16.
Consensus Ratings for HCi VioCare (OTCBB:VICA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for HCi VioCare (OTCBB:VICA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for HCi VioCare (OTCBB:VICA)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for HCi VioCare (OTCBB:VICA)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for HCi VioCare (OTCBB:VICA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for HCi VioCare (OTCBB:VICA)Insider Trades by Quarter for HCi VioCare (OTCBB:VICA)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|4/16/2014||Sotirios Leontaritis||CEO||Sell||724,560||$0.80||$579,648.00|| |
|4/3/2014||Sotirios Leontaritis||CEO||Sell||200,000||$1.00||$200,000.00|| |
Headline Trends for HCi VioCare (OTCBB:VICA)
Latest Headlines for HCi VioCare (OTCBB:VICA)
No headlines for this company have been tracked by MarketBeat.com